GETI-B vs SOBI: Side-by-Side Comparison
Compare Getinge AB ser. B (GETI-B) and Swedish Orphan Biovitrum AB (publ) (SOBI) side by side: market cap SEK 54.43B vs SEK 162.86B, P/E 23.1 vs 178.3. Financials, growth and model signals on Bullrun.
| Metric | GETI-B | SOBI |
|---|---|---|
| Company | Getinge AB ser. B | Swedish Orphan Biovitrum AB (publ) |
| Country / Exchange | Sweden · ST | Sweden · ST |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Drug Manufacturers - Specialty & Generic |
| Market cap | SEK 54.43B | SEK 162.86B |
| P/E ratio | 23.1 | 178.3 |
| Dividend yield | 2.42% | — |
| Valuation model | 14.1% undervalued | 70.6% overvalued |
| Revenue (FY2024) | SEK 34.76B | SEK 26.03B |
| Revenue growth YoY | +9.2% | +17.6% |
| Net income | SEK 1.65B | SEK 3.88B |
| Gross margin | 46.5% | 77.8% |
| Diluted EPS | 6.01 | — |